Perceptions of Medication Can Predict MS Treatment Adherence, Persistence
Perceptions of a medication can predict treatment adherence and persistence — sticking with the same therapy — in people with…
Articles by Diana Campelo Delgado
Restless Legs Syndrome More Common With Greater Disability, Spinal Lesions
Restless legs syndrome, the name given to the considerable discomfort people feel in their lower limbs, accompanied by an irresistible urge…
MS Trust Invites Youth Touched by Disease to Join as ‘MSTV Reporters’
The MS Trust welcomes adolescents with a connection to multiple sclerosis (MS) to join as reporters for its YouTube…
Dosing Begins in Trial of Anokion’s ANK-700 for RRMS
A Phase 1 clinical trial investigating ANK-700 as a means to restore immune tolerance to myelin in people…
UK ‘Mega-trial’ Testing Multiple MS Therapies to Start This Year
Doctors in the U.K. are planning a “mega-trial” to investigate several marketed therapies — at the same time — as…
ThermApparel Marks 4th Anniversary of Cooling Vest
ThermApparel is observing Multiple Sclerosis Awareness Month by  celebrating the fourth anniversary of its cooling vest, designed for multiple sclerosis…
MS in Harmony is First Digital Music Therapy for MS Patients
Bristol Myers Squibb (BMS) and the American Music Therapy Association (AMTA) are partnering with singer and actor Ben Platt,…
MS Society in UK Commits to Raising $5.2M for Research
The MS Society in the U.K. is hoping to raise £3.7 million ($5.2 million) to fund research aimed at…
Johns Hopkins Neuroscientist Wins 2020 Barancik Prize for Innovation
The 2020 Barancik Prize for Innovation in MS Research has been awarded to neuroscientist Dwight E. Bergles, PhD, a…
Early-life Trauma Affects MS Development, Treatment in Mice
Childhood trauma can affect disease progression of multiple sclerosis (MS) and treatment in adulthood, a study in mice suggests.
Telemedicine Found Effective During Italy’s COVID-19 Lockdown
Telemedicine is a feasible and effective method of remote care for multiple sclerosis (MS) patients during the COVID-19 pandemic,…
Lemtrada May Slow MS Disease Progression, Long-term Study Suggests
Lemtrada (alemtuzumab) may slow the progression of multiple sclerosis (MS) and lower the conversion rate of relapsing-remitting MS (RRMS)…
CXCL13, Inflammatory Marker, May Be Good at Predicting Likely MS Activity
CXCL13, an inflammatory biomarker, may be a good marker of likely future disease activity in people with multiple sclerosis (MS),…
MS Risk May Be Higher for Children of Diabetic Mothers, Study Suggests
Children of diabetic mothers may be at more risk of developing multiple sclerosis (MS), a Danish national study suggests. The…
Primary Headaches Prevalent in MS, Research Reveals
The prevalence of primary headaches — those with no clear cause — is high among patients with multiple sclerosis…
Sanofi Enrolling for 2 GEMINI Trials Testing Tolebrutinib vs. Aubagio for Relapsing MS
Two global Phase 3 clinical trials, both comparing Sanofi Genzyme’s investigational tolebrutinib with its approved therapy Aubagio,…
Stem Cell Transplant Reduces Relapses and Disability in RRMS, Study Suggests
Autologous hematopoietic stem cell transplant (AHSCT) induces a reduction in relapse rate and physical disability in patients with…
MS Has Greater Impact on Women’s Physical Activity, Study Reveals
Multiple sclerosis (MS) has a greater impact on women, reducing their levels of physical activity and increasing sedentary behavior,…
Better Repair of Nerve Insulation May Lead to New MS Treatments
There may be a better way of repairing the insulation surrounding damaged neurons that could lead to new treatments for…
No Association Between Skin Condition Vitiligo and MS, Study Asserts
There is no significant association between multiple sclerosis (MS) and vitiligo, a skin condition in which patches of skin…
Variants in Key Gene Interact With Insults Like EBV to Cause MS, Study Suggests
The HLA-DR15 haplotype — a set of gene variants that tend to be inherited together — in the HLA-DRB1…
NanoStilbene Better Than Copaxone at Reducing MS Symptoms in Mouse Model
The nutritional supplement NanoStilbene, developed by Therapeutic Solutions International, worked better to reduce neurological damage and disease symptoms…
Aslan Pharmaceuticals to Develop Aslan003 for Autoimmune Conditions
Aslan Pharmaceuticals announced it will develop Aslan003, a potent and highly selective next-generation modulator of the immune system,…